PD-L1 anticorps (Extracellular Domain) (PE)
Aperçu rapide pour PD-L1 anticorps (Extracellular Domain) (PE) (ABIN1449174)
Antigène
Voir toutes PD-L1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- Extracellular Domain
-
Specificité
- This antibody reacts with human PD-1.
-
Purification
- Protein A agarose
-
Immunogène
- Fusion protein of the extracellular domain of human PD-1 and the constant region of human gamma1 heavy chain
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS, 0.09 % NaN3, 1 % BSA
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 2-8 °C.
-
-
- PD-L1 (CD274 (PD-L1))
-
Autre désignation
- CD274 / PDL1
-
Sujet
- Human PD-1 (programmed death-1) is a 55 kDa member of the immunoglobulin superfamily that is induced in cells that are undergoing apoptosis. The PD-1 protein contains an immunoreceptor tyrosine-based inhibitory motif and is expressed predominantly on activated T and B lymphocytes. PD-1 plays a key role in peripheral tolerance and autoimmune disease and is thought to be involved in the maintenance of peripheral self-tolerance by serving as a negative regulator of immune responses. Two novel members of the B7 family have been identified as PD-1 ligands, PD-L1 (B7-H1) and PD-L2 (B7-DC). Evidence reported to date suggests overlapping functions for these two PD-1 ligands and their constitutive expression on some normal tissues and up-regulation on activated antigen presenting cells.Synonyms: B7 homolog 1, B7H1, PD-L1, PDCD1 ligand 1, PDCD1L1, PDCD1LG1, Programmed cell death 1 ligand 1, Programmed death ligand 1
-
ID gène
- 29126
-
NCBI Accession
- NP_054862
-
UniProt
- Q9NZQ7
-
Pathways
- Cancer Immune Checkpoints
Antigène
-